After discontinuing its internal GLP-1 in May of 2025 for causing liver issues, Pfizer won a bidding war against seven other companies for Metsera, which is developing a variety of incretin assets, paying $10 billion in one of 2025s largest M&A deals
Research suggests that by blocking NNMT, 5-Amino-1MQ prevents the degradation of nicotinamide, theoretically preserving the endogenous pool of NAD
As a result, women have been encouraged to pair their use with effective contraception
How to Actually Use GHK-Cu (Route and Dosing Matter) This is where most people go astray because they buy overpriced topical serums based on Instagram ads and wonder why results are minimal
However, they cannot easily be prevented
A hard safety review to limit initial opioid prescription fills for the treatment of acute pain to no more than a 7-day supply